Genetic variants that lower LDL cholesterol frequently also affect other lipid traits such as triglycerides and HDL
3 events · 1 assessment · 1 decision
Structured and assessed
First pass. Left the claim atomic: it is a single, reusable empirical proposition about lipid-trait pleiotropy that does not turn on distinct disputed sub-propositions, so no decomposition or named arguments were warranted (do not split to fill a quota). Set importance to 0.3 (contestation 0.15): a settled GWAS fact, load-bearing within the narrow MR-of-LDL subfield but uncontested, so getting it right is cheap. Assessed VERIFIED (confidence 0.9, credence 0.95) from the external literature (Global Lipids Genetics Consortium and multi-trait GWAS showing loci shared across LDL, HDL, TG, TC; MR pleiotropy-robust methods presuppose it). "Frequently" is accurate, not absolute. Notifying the one local dependent, whose CONTRADICTS relation makes this newly-verified premise material context.
Assessed Verified
verdict confidence 0.90 · credence 0.95
Genome-wide association studies of blood lipids consistently find that a substantial share of loci influencing LDL cholesterol are also associated with triglycerides, HDL cholesterol, or total cholesterol, rather than acting on LDL alone. Large consortium analyses, including work from the Global Lipids Genetics Consortium, report many loci with associations spanning several lipid fractions alongside loci that appear trait-specific. This shared genetic architecture is precisely why Mendelian randomization studies of LDL routinely apply multivariable and pleiotropy-robust methods to separate LDL's effect from that of correlated lipid traits. The qualifier "frequently" is well matched to the evidence: pleiotropy across lipid traits is common though not universal, since a meaningful subset of LDL-associated variants remain relatively specific.
Claim entered the graph